SCHEMBL2074385

SCHEMBL2074385

O=[C]Nc1cc(Cl)cc(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.42
RAPGEF4 Q8WZA2 1/20 0.40
ALDH1A1 P00352 2/20 0.39
MAPT P10636 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
RAB9A P51151 1/20 0.38
FDPS P14324 1/20 0.38
DEPTOR Q8TB45 1/20 0.37
IDO1 P14902 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
ALOX12 P18054 1/20 0.35
FKBP1A P62942 1/20 0.35
P2RY1 P47900 1/20 0.35
POLB P06746 1/20 0.35
ACP1 P24666 1/20 0.34
MAP2K1 Q02750 1/20 0.33
TPMT P51580 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2093693 0.77 RAPGEF4 (0.42) TSHRRAPGEF4ALDH1A1
SCHEMBL57436 0.77 MEN1 (0.53) TSHRALDH1A1MAPTMEN1KMT2A
SCHEMBL7533055 0.75 S1PR2 (0.50)
SCHEMBL8829718 0.74 TSHR (0.42) TSHRRAPGEF4ALDH1A1MAPTMEN1
SCHEMBL1486303 0.74 NPC1 (0.43) TSHRALDH1A1MAPTMEN1KMT2A
SCHEMBL10466069 0.73 HSD17B10 (0.44) TSHRALDH1A1MAPTGAAALOX12
SCHEMBL2097674 0.72 ALDH1A1 (0.39) TSHRRAPGEF4ALDH1A1MAPTMEN1
SCHEMBL424460 0.70 RAPGEF4 (0.42) TSHRRAPGEF4ALDH1A1MAPTMEN1
SCHEMBL7497080 0.69 MEN1 (0.52) TSHRRAPGEF4ALDH1A1MAPTMEN1
SCHEMBL2095962 0.69 EPHX1 (0.52) RAPGEF4ALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113929695-A Sulfenimide psoralen derivatives, and preparation method and application thereof 南开大学 2022-01-14 CN claimed
CN-102633892-B Polysaccharide derivates and the agent for separating optical isomers containing this polysaccharide derivates DAICEL CHEMICAL INDUSTRIES CO., LTD. (JP) 2016-02-24 CN claimed
EP-1189891-A1 TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF LION Bioscience AG (DE) 2002-03-27 EP claimed
US-6362342-B1 BIOSYNTHESIS; DRUG LIBRARIES LION BIOSCIENCE AG (DE) 2002-03-26 US claimed
WO-2001000594-A1 TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF LION BIOSCIENCE AG (DE) 2001-01-04 WO claimed
CN-113929695-B Sulfimide psoralen derivatives, and preparation method and application thereof 南开大学 2024-06-07 CN disclosed
CN-113929695-A Sulfenimide psoralen derivatives, and preparation method and application thereof 南开大学 2022-01-14 CN disclosed
US-20180056270-A1 AMYLOSE DERIVATIVE AND OPTICAL ISOMER SEPARATING AGENT CONTAINING SAME DAICEL CORPORATION (JP) 2018-03-01 US disclosed
EP-3071560-B1 N-ACYLIMINO HETEROCYCLIC COMPOUNDS BASF SE (DE) 2018-01-10 EP disclosed
CN-107245055-A The preparation method of iprodione 江苏蓝丰生物化工股份有限公司 2017-10-13 CN disclosed
US-9783523-B2 N-acylimino heterocyclic compounds BASF SE (DE) 2017-10-10 US disclosed
EP-2592095-B1 POLYSACCHARIDE DERIVATIVE, METHOD FOR PRODUCING THE SAME, AND SEPARATING AGENT DAICEL CORP (JP) 2017-05-24 EP disclosed
US-5047521-A Anticarcinogenic agents OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-09-10 US disclosed
EP-0436902-A1 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-07-17 EP disclosed
US-4983609-A Anticancer agents OTSUKA PHARMACEUTICAL (JP) 1991-01-08 US disclosed
US-4864021-A ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-09-05 US disclosed
EP-0323441-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-07-05 EP disclosed
EP-0247381-A2 5-flurorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1987-12-02 EP disclosed
EP-0180897-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-14 EP disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 EP disclosed